APT Begin Period Cash Flow from 2010 to 2025

688617 Stock   390.00  3.00  0.76%   
APT Medical's Begin Period Cash Flow is increasing over the years with slightly volatile fluctuation. Begin Period Cash Flow is expected to dwindle to about 159 M. Begin Period Cash Flow is the amount of cash APT Medical has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. View All Fundamentals
 
Begin Period Cash Flow  
First Reported
2019-12-31
Previous Quarter
654.2 M
Current Value
721 M
Quarterly Volatility
311.2 M
 
Covid
Check APT Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among APT Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 76.1 M, Interest Expense of 4.5 M or Selling General Administrative of 192.1 M, as well as many indicators such as . APT financial statements analysis is a perfect complement when working with APT Medical Valuation or Volatility modules.
  
This module can also supplement various APT Medical Technical models . Check out the analysis of APT Medical Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in APT Stock

APT Medical financial ratios help investors to determine whether APT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in APT with respect to the benefits of owning APT Medical security.